1. Home
  2. ENS vs IOVA Comparison

ENS vs IOVA Comparison

Compare ENS & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EnerSys

ENS

EnerSys

HOLD

Current Price

$169.39

Market Cap

6.0B

Sector

Technology

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$3.69

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENS
IOVA
Founded
1991
2007
Country
United States
United States
Employees
9200
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
1.6B
IPO Year
2004
2008

Fundamental Metrics

Financial Performance
Metric
ENS
IOVA
Price
$169.39
$3.69
Analyst Decision
Strong Buy
Buy
Analyst Count
3
10
Target Price
$193.00
$9.11
AVG Volume (30 Days)
310.0K
17.4M
Earning Date
02-04-2026
05-07-2026
Dividend Yield
0.59%
N/A
EPS Growth
38.31
14.84
EPS
5.65
N/A
Revenue
$216,125,000.00
N/A
Revenue This Year
$4.63
$51.55
Revenue Next Year
$3.46
$37.55
P/E Ratio
$31.36
N/A
Revenue Growth
15.85
N/A
52 Week Low
$76.57
$1.64
52 Week High
$194.77
$5.63

Technical Indicators

Market Signals
Indicator
ENS
IOVA
Relative Strength Index (RSI) 51.69 49.75
Support Level $149.66 $2.02
Resistance Level $184.13 $4.34
Average True Range (ATR) 5.77 0.36
MACD 1.49 -0.13
Stochastic Oscillator 60.07 14.51

Price Performance

Historical Comparison
ENS
IOVA

About ENS EnerSys

EnerSys provides stored energy solutions for industrial applications. It also manufactures and distributes energy systems solutions and motive power batteries, specialty batteries, battery chargers, power equipment, battery accessories, and outdoor equipment enclosure solutions to customers. Energy Systems that combine enclosures, power conversion, power distribution, and energy storage are used in the telecommunication and broadband, utility industries, uninterruptible power supplies, and numerous applications requiring stored energy solutions. Its segments include Energy Systems, Motive Power, and Specialty.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: